Ultra-Test Injectable Compounded Drug Recalled for Lack of Sterility Assurance
Talon Compounding Pharmacy is recalling Ultra-Test (CYP 80%/PROP 20%) 200mg/ml injectable across the United States, Puerto Rico, and Washington, D.C. due to lack of assurance of sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This recall is classified as FDA Class II. Lack of sterility assurance in an injectable pharmaceutical product presents a direct risk of serious infection and potential hospitalization, meeting the criteria for a Severe rating under the Class II with significant risk of harm standard.
Plain-English summary
Vita Pharmacy, LLC, doing business as Talon Compounding Pharmacy, located at 2950 Thousand Oaks Drive, Suite 25, San Antonio, Texas 78247, is recalling Ultra-Test (CYP 80%/PROP 20%) 200mg/ml injectable due to lack of assurance of sterility.
The product is a compounded prescription injectable. A total of 23 vials are subject to this recall, distributed across the United States including Washington, D.C. and Puerto Rico. The affected lots and expiration dates are: T1008032021:86 (BUD 01/30/2022); T1004192021:25 (BUD 10/16/2021); T1005252021:33 (BUD 11/21/2021); and T1009082021:96 (BUD 03/07/2022).
Patients who have received this product should contact their physician or healthcare provider. Healthcare providers and patients with questions about this recall are advised to contact the recalling firm or the FDA.
The recalled product
- Product
- ULTRA-TEST (CYP 80%/PROP 20%) 200MG/ML INJ #1 200MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Category
- Drug — Compounded Injectable
- Affected units
- 23
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot: T1008032021:86 BUD: 01/30/2022
- T1004192021:25 BUD: 10/16/2021
- T1005252021:33 BUD: 11/21/2021
- T1009082021:96 BUD: 03/07/2022
Distribution
Part of a larger recall action
This product is one of 130 recalled by Vita Pharmacy, LLC dba Talon Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 130 products in this recall →Related recalls
Same manufacturer · Vita Pharmacy, LLC dba Talon Compounding Pharmacy
See all →- HighInjectable testosterone and dutasteride product recall for sterility assurance failure
FDA (Drugs) · 2021-11-17
- HighIC B Complex Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
- SevereTRI-MIX Injectable by Talon Compounding Pharmacy Recalled for Sterility Assurance
FDA (Drugs) · 2021-11-17
- SevereInjectable Steroid Combination Product Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
- HighTestosterone Bi-Blend Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
Same hazard · lack of sterility assurance
See all →- SevereNAD+ Pre-Filled Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2025-07-02
- ModerateTirzepatide Injections Pre-filled Syringe Recalled for Sterility Assurance
FDA (Drugs) · 2025-07-02
- HighHydromorphone Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2024-04-03
- HighPHENYLephrine HCl Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2024-04-03
- HighFentanyl Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11